UK markets closed

Zepp Health Corporation (ZEPP)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.0353+0.0053 (+0.51%)
As of 12:44PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 62.87M
Enterprise value 130.74M
Trailing P/E N/A
Forward P/E 3.12
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.15
Price/book (mrq)0.18
Enterprise value/revenue 0.04
Enterprise value/EBITDA -0.51

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-16.94%
S&P500 52-week change 329.57%
52-week high 32.1000
52-week low 30.9010
50-day moving average 31.2358
200-day moving average 31.2349

Share statistics

Avg vol (3-month) 373.93k
Avg vol (10-day) 3117.01k
Shares outstanding 561.04M
Implied shares outstanding 661.04M
Float 8101.86M
% held by insiders 13.36%
% held by institutions 129.74%
Shares short (15 Mar 2024) 44.1k
Short ratio (15 Mar 2024) 40.04
Short % of float (15 Mar 2024) 4N/A
Short % of shares outstanding (15 Mar 2024) 40.01%
Shares short (prior month 15 Feb 2024) 413.64k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 315 Apr 2022
Ex-dividend date 425 Mar 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -8.50%
Operating margin (ttm)0.89%

Management effectiveness

Return on assets (ttm)-2.65%
Return on equity (ttm)-8.19%

Income statement

Revenue (ttm)2.5B
Revenue per share (ttm)41.05
Quarterly revenue growth (yoy)-44.00%
Gross profit (ttm)N/A
EBITDA -148.49M
Net income avi to common (ttm)-212.12M
Diluted EPS (ttm)-0.6400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)985.62M
Total cash per share (mrq)4.08
Total debt (mrq)886.83M
Total debt/equity (mrq)35.41%
Current ratio (mrq)2.04
Book value per share (mrq)41.28

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A